Stay updated on Cemiplimab in NSCLC: European Clinical Trial
Sign up to get notified when there's something new on the Cemiplimab in NSCLC: European Clinical Trial page.

Latest updates to the Cemiplimab in NSCLC: European Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRecord History now includes new additions for Study Status and Contacts/Locations (version 3.5.0, last update 2026-03-18).SummaryDifference0.5%

- Check18 days agoChange DetectedRevision: v3.4.3 is added and Revision: v3.4.2 is removed, updating the page's version label.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedOn 2026-02-20, Contacts/Locations and Study Status were added to the study record history. On 2026-02-18, the history now shows 20 entries.SummaryDifference0.4%

- Check47 days agoChange DetectedAdded a new version entry: Revision: v3.4.2. Removed the funding-status notice and the prior Revision: v3.4.1 entry.SummaryDifference0.7%

- Check54 days agoChange DetectedA site-wide notice about a lapse in government funding is now displayed. The footer revision tag has been updated from v3.4.0 to v3.4.1.SummaryDifference0.7%

- Check61 days agoChange DetectedThe update adds UI enhancements to the record history, including a glossary toggle, green highlights for additions, red highlights for deletions, and a new revision label (v3.4.0). These changes do not modify the underlying study data.SummaryDifference0.9%

Stay in the know with updates to Cemiplimab in NSCLC: European Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cemiplimab in NSCLC: European Clinical Trial page.